The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr13
start 91350605
end 91350688
ID MI0000071
miRNA_name hsa-miR-17
methods qRT-PCR,etc.
regulated up
Function Description In summary, our study indicated the upregulation ofmiR©17, and downregulation of miR©25 and miR©133 inpatient¡¯s serum.Examination based on serum miRNA profiling wasfollowed by qRT©PCR validation, so we identified threemiRNAs (miR©17, miR©25, and miR©133) that areinvolved in patients with breast cancer relative to healthycontrols. Detection of the expression levels of each of thethree miRNAs could significantly distinguish breastcancer and healthy controls. Moreover, these miRNAswere associated with the several important cancer© elatedpathways and breast cancer survival. These resultssuggest that the identified miRNAs may play importantroles in the breast cancer development and progression,and may serve as potential biomarkers for the earlydetection of breast cancer
PMID 30485486
year 2018
Title Expression of Circulating miR-17, miR-25, and miR-133 in Breast Cancer Patients
drug X
circulating V
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China